Showing results (1-10 of 333) with videos related to
Sort By:
Pageof 34
Expert Opinion on Pharmacotherapy|May 6, 2016
Treatment with non-steroidal anti-inflammatory drugs in patients after myocardial infarction - a systematic reviewLena Boulakh, Gunnar H GislasonJAMA Dermatology|February 18, 2016
Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis SuppurativaAlexander Egeberg, Gunnar H Gislason, Peter R HansenEuropean Journal of Internal Medicine|June 25, 2016
The increasing incidence of infective endocarditis in Denmark, 1994-2011Purnima Erichsen, Gunnar H Gislason, Niels Eske BruunEuropean Heart Journal. Cardiovascular Pharmacotherapy|March 15, 2024
Use of proton pump inhibitors is associated with increased risk of out-of-hospital cardiac arrest in the general population: a nested case-control studyTalip E Eroglu, Ruben Coronel, Gunnar H GislasonQualitative Health Research|September 19, 2019
Chronic Paradoxes: A Systematic Review of Qualitative Family Perspectives on Living With Congenital Heart DefectsMarie Kofod Svensson, Ayo Wahlberg, Gunnar H GislasonCardiovascular Diabetology|June 8, 2010
Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registryThomas Kümler, Gunnar H Gislason, Lars Køber, et al.Current Opinion in Cardiology|October 1, 2013
Time-perspective in cardiovascular risk of NSAID use after first-time myocardial infarctionAnne-Marie Schjerning Olsen, Gunnar H Gislason, Emil L FosbølCurrent Pharmaceutical Design|June 26, 2012
Risk of bleeding related to antithrombotic treatment in cardiovascular diseaseRikke Sørensen, Jonas B Olesen, Mette Charlot, et al.Acta Orthopaedica|May 14, 2021
Sex differences in incidence rate, and temporal changes in surgical management and adverse events after hip fracture surgery in Denmark 1997-2017: a register-based study of 153,058 hip fracture patientsLiv R Wahlsten, Henrik Palm, Gunnar H Gislason, et al.Ugeskrift for Laeger|July 27, 2010
[Psoriasis and atherothrombotic disease]Ole Ahlehoff, Gunnar H Gislason, Lone Skov, et al.Pageof 34